Complete Filing Data
SHOPIFY INC. reported Stockholders Equity of $13.47 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SHOPIFY INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|
| Revenue * | $11.56B | $8.88B | $7.06B | $5.60B | $205.2M | $105.0M | $50.3M |
| Comprehensive Income Net Of Tax | $1.24B | $2.01B | $152.0M | -$3.47B | -$18.8M | -$22.3M | -$4.8M |
| Selling And Marketing Expense | $1.66B | $1.39B | $1.22B | $1.23B | $70.4M | $45.9M | $23.4M |
| Research And Development Expense | $1.54B | $1.37B | $1.73B | $1.50B | $39.7M | $25.9M | $13.7M |
| Operating Income Loss | $1.47B | $1.08B | -$1.42B | -$822.0M | -$17.8M | -$21.6M | -$4.3M |
| Operating Expenses | $4.09B | $3.40B | $4.93B | $3.58B | $128.8M | $83.4M | $41.0M |
| Nonoperating Income Expense | $41.0M | $1.15B | $1.60B | -$2.80B | -$1.0M | -$696.0K | -$568.0K |
| Net Income Loss | $1.23B | $2.02B | $132.0M | -$3.46B | -$18.8M | -$22.3M | -$4.8M |
| Interest Income Expense Nonoperating Net | $331.0M | $308.0M | $241.0M | $75.0M | $200.0K | $57.0K | $42.0K |
| Gross Profit | $5.56B | $4.47B | $3.52B | $2.75B | $111.1M | $61.8M | $36.7M |
| General And Administrative Expense | $471.0M | $410.0M | $491.0M | $708.0M | $18.7M | $11.6M | $4.0M |
| Cost Of Goods And Services Sold | $6.00B | $4.41B | $3.55B | $2.85B | |||
| Income Tax Expense Benefit | $278.0M | $209.0M | $53.0M | -$163.0M | |||
| Revenue Related To Non Cash Consideration | $49.0M | $94.0M | $158.0M | $121.0M | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $11.0M | -$14.0M | $20.0M | -$10.0M | |||
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent | $4.0M | -$5.0M | $0.00 | $0.00 | |||
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent | $15.0M | -$19.0M | $20.0M | -$10.0M | |||
| Income Taxes Paid Net | $194.0M | $116.0M | $50.0M | $27.0M | |||
| Deferred Income Tax Liabilities Net | $55.0M | $73.0M | $6.0M | ||||
| Income Loss From Equity Method Investments | -$40.0M | -$138.0M | -$58.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Revenue * | $2.84B | $2.68B | $2.36B | $2.16B | $2.05B | $1.86B |
| Comprehensive Income Net Of Tax | $258.0M | $917.0M | -$678.0M | $832.0M | $170.0M | -$281.0M |
| Selling And Marketing Expense | $410.0M | $415.0M | $405.0M | $331.0M | $353.0M | $361.0M |
| Research And Development Expense | $375.0M | $394.0M | $377.0M | $332.0M | $349.0M | $335.0M |
| Operating Income Loss | $343.0M | $291.0M | $203.0M | $283.0M | $241.0M | $86.0M |
| Operating Expenses | $1.05B | $1.01B | $966.0M | $835.0M | $804.0M | $871.0M |
| Nonoperating Income Expense | -$35.0M | $788.0M | -$973.0M | $577.0M | -$38.0M | -$342.0M |
| Net Income Loss | $264.0M | $906.0M | -$682.0M | $828.0M | $171.0M | -$273.0M |
| Interest Income Expense Nonoperating Net | $81.0M | $106.0M | $65.0M | $77.0M | $80.0M | $79.0M |
| Gross Profit | $1.39B | $1.30B | $1.17B | $1.12B | $1.05B | $957.0M |
| General And Administrative Expense | $115.0M | $122.0M | $109.0M | $114.0M | $60.0M | $124.0M |
| Cost Of Goods And Services Sold | $1.45B | $1.38B | $1.19B | $1.04B | $1.00B | $904.0M |
| Income Tax Expense Benefit | $44.0M | $173.0M | -$88.0M | $32.0M | $32.0M | $17.0M |
| Revenue Related To Non Cash Consideration | $12.0M | $12.0M | $13.0M | $19.0M | $21.0M | $35.0M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$6.0M | $11.0M | $4.0M | $4.0M | -$1.0M | -$8.0M |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent | -$3.0M | $5.0M | $1.0M | $0.00 | $0.00 | $0.00 |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent | -$9.0M | $16.0M | $5.0M | $4.0M | -$1.0M | -$8.0M |
| Income Taxes Paid Net | $23.0M | $61.0M | $27.0M | $14.0M | $40.0M | $9.0M |
| Deferred Income Tax Liabilities Net | $29.0M | $36.0M | $5.0M | |||
| Income Loss From Equity Method Investments | -$21.0M | -$24.0M | -$23.0M | -$28.0M | -$44.0M | -$44.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $13.47B | $11.56B | $9.07B | $8.24B | $11.13B | $195.3M | $67.7M | $85.4M | $18.0M |
| Goodwill | $491.0M | $452.0M | $427.0M | $1.84B | $2.4M | $2.4M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.55B | $1.50B | $1.41B | $1.65B | $2.50B | ||||
| Contract With Customer Liability Noncurrent | $98.0M | $147.0M | $196.0M | $268.0M | |||||
| Contract With Customer Liability Current | $300.0M | $283.0M | $302.0M | $296.0M | |||||
| Cash And Cash Equivalents At Carrying Value | $1.55B | $1.50B | $1.41B | $110.1M | $42.0M | $83.5M | $17.7M | ||
| Notes And Loans Receivable Net Current | $1.78B | $1.22B | $816.0M | $580.0M | |||||
| Retained Earnings Accumulated Deficit | $2.86B | $1.63B | -$390.0M | -$47.9M | -$29.1M | ||||
| Property Plant And Equipment Net | $53.0M | $47.0M | $49.0M | $33.0M | $21.7M | ||||
| Prepaid Expense And Other Assets Current | $234.0M | $209.0M | $169.0M | $6.2M | $1.5M | ||||
| Marketable Securities Current | $4.23B | $3.98B | $3.60B | $80.1M | $17.7M | ||||
| Liabilities Noncurrent | $324.0M | $410.0M | $1.34B | $11.2M | $7.7M | ||||
| Liabilities Current | $1.39B | $1.96B | $898.0M | $37.2M | $19.8M | ||||
| Liabilities And Stockholders Equity | $15.19B | $13.92B | $11.30B | $243.7M | $95.2M | ||||
| Common Stock Value | $10.38B | $9.63B | $9.20B | $231.5M | $4.1M | ||||
| Assets Noncurrent | $6.89B | $6.67B | $5.02B | $41.2M | $26.8M | ||||
| Assets Current | $8.30B | $7.25B | $6.28B | $202.5M | $68.4M | ||||
| Assets | $15.19B | $13.92B | $11.30B | $243.7M | $95.2M | ||||
| Accounts Payable And Accrued Liabilities Current | $1.08B | $737.0M | $579.0M | $23.7M | $12.5M | ||||
| Unrealized Gain Loss On Investments | -$153.0M | $992.0M | $1.42B | -$2.92B | |||||
| Equity Method And Other Investments Unrealized Gain Loss | -$186.0M | $988.0M | $1.42B | -$3.00B | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $47.0M | $85.0M | -$236.0M | -$854.0M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.0M | -$10.0M | $4.0M | ||||||
| Accounts And Other Receivables Net Current | $500.0M | $342.0M | $282.0M | ||||||
| Operating Lease Right Of Use Asset | $88.0M | $93.0M | $98.0M | ||||||
| Operating Lease Liability Noncurrent | $171.0M | $190.0M | $217.0M | ||||||
| Operating Lease Liability Current | $17.0M | $18.0M | $17.0M | ||||||
| Equity Method And Other Investments Realized Gain | $33.0M | $3.0M | -$5.0M | $124.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $12.51B | $12.12B | $11.05B | $10.12B | $9.17B | $8.89B |
| Goodwill | $491.0M | $491.0M | $491.0M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.41B | $1.54B | $1.31B | $1.51B | $1.54B | $1.62B |
| Contract With Customer Liability Noncurrent | $110.0M | $123.0M | $135.0M | $159.0M | $170.0M | $183.0M |
| Contract With Customer Liability Current | $300.0M | $298.0M | $295.0M | $290.0M | $298.0M | $296.0M |
| Cash And Cash Equivalents At Carrying Value | $2.41B | $1.54B | $1.31B | |||
| Notes And Loans Receivable Net Current | $1.73B | $1.60B | $1.39B | |||
| Retained Earnings Accumulated Deficit | $2.12B | $1.85B | $947.0M | |||
| Property Plant And Equipment Net | $51.0M | $46.0M | $46.0M | |||
| Prepaid Expense And Other Assets Current | $227.0M | $234.0M | $242.0M | |||
| Marketable Securities Current | $3.94B | $4.28B | $4.21B | |||
| Liabilities Noncurrent | $315.0M | $359.0M | $340.0M | |||
| Liabilities Current | $2.21B | $2.08B | $2.01B | |||
| Liabilities And Stockholders Equity | $15.04B | $14.56B | $13.40B | |||
| Common Stock Value | $10.12B | $9.99B | $9.83B | |||
| Assets Noncurrent | $6.33B | $6.56B | $5.96B | |||
| Assets Current | $8.71B | $8.00B | $7.45B | |||
| Assets | $15.04B | $14.56B | $13.40B | |||
| Accounts Payable And Accrued Liabilities Current | $974.0M | $841.0M | $776.0M | |||
| Unrealized Gain Loss On Investments | -$62.0M | $682.0M | -$1.02B | $512.0M | -$76.0M | -$373.0M |
| Equity Method And Other Investments Unrealized Gain Loss | -$62.0M | $681.0M | -$1.02B | $512.0M | -$79.0M | -$373.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $872.0M | $233.0M | -$189.0M | -$34.0M | -$82.0M | $210.0M |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.0M | $5.0M | -$6.0M | |||
| Accounts And Other Receivables Net Current | $396.0M | $350.0M | $297.0M | |||
| Operating Lease Right Of Use Asset | $94.0M | $97.0M | $105.0M | |||
| Operating Lease Liability Noncurrent | $176.0M | $200.0M | $200.0M | |||
| Operating Lease Liability Current | $19.0M | $20.0M | $19.0M | |||
| Equity Method And Other Investments Realized Gain | $0.00 | $1.0M | $0.00 | $3.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|
| Proceeds From Stock Options Exercised | $232.0M | $61.0M | $60.0M | $18.0M | $1.6M | $140.0K | $295.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $6.55B | $7.46B | $5.59B | $6.89B | $48.4M | $2.4M | $0.00 |
| Payments To Acquire Property Plant And Equipment | $26.0M | $19.0M | $39.0M | $50.0M | $16.5M | $20.6M | $3.5M |
| Payments To Acquire Marketable Securities | $7.04B | $8.40B | $5.84B | $5.01B | $111.2M | $20.1M | $0.00 |
| Payments To Acquire Businesses Net Of Cash Acquired | $56.0M | $30.0M | $31.0M | $1.75B | $0.00 | $0.00 | $828.0K |
| Net Cash Provided By Used In Operating Activities | $2.03B | $1.62B | $944.0M | -$136.0M | $15.8M | -$801.0K | $1.4M |
| Net Cash Provided By Used In Investing Activities | -$1.19B | -$1.59B | -$1.24B | -$719.0M | -$83.8M | -$40.4M | -$5.3M |
| Net Cash Provided By Used In Financing Activities | -$811.0M | $61.0M | $60.0M | $18.0M | $137.9M | $140.0K | $70.1M |
| Depreciation Depletion And Amortization | $31.0M | $36.0M | $70.0M | $93.0M | $7.2M | $4.7M | $1.8M |
| Increase Decrease In Deferred Income Taxes | $14.0M | -$78.0M | $1.0M | $187.0M | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $15.0M | -$6.0M | $4.0M | -$17.0M | |||
| Payments To Acquire Equity And Other Investments | $99.0M | $137.0M | $364.0M | $635.0M | |||
| Proceeds From Principal Repayments On Loans And Leases Held For Investment | $3.44B | $2.54B | $1.34B | $367.0M | |||
| Payments To Acquire Loans Held For Investment | $4.01B | $3.01B | $1.86B | $526.0M | |||
| Increase Decrease In Finance Receivables | $141.0M | $82.0M | -$214.0M | $23.0M | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $262.0M | $110.0M | $69.0M | $28.0M | |||
| Increase Decrease In Accounts And Other Receivables | $219.0M | $148.0M | $98.0M | $105.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Proceeds From Stock Options Exercised | $24.0M | $44.0M | $59.0M | $6.0M | $3.0M | $3.0M |
| Proceeds From Sale And Maturity Of Marketable Securities | $1.96B | $1.46B | $1.33B | $1.84B | $1.66B | $2.15B |
| Payments To Acquire Property Plant And Equipment | $6.0M | $6.0M | $4.0M | $2.0M | $7.0M | $6.0M |
| Payments To Acquire Marketable Securities | $1.46B | $1.46B | $1.72B | $2.09B | $1.83B | $2.14B |
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $0.00 | $56.0M | $4.0M | $26.0M | $0.00 |
| Net Cash Provided By Used In Operating Activities | $513.0M | $428.0M | $367.0M | $423.0M | $340.0M | $238.0M |
| Net Cash Provided By Used In Investing Activities | $335.0M | -$252.0M | -$619.0M | -$474.0M | -$424.0M | -$27.0M |
| Net Cash Provided By Used In Financing Activities | $24.0M | $44.0M | $59.0M | $6.0M | $3.0M | $3.0M |
| Depreciation Depletion And Amortization | $8.0M | $8.0M | $8.0M | $8.0M | $10.0M | $10.0M |
| Increase Decrease In Deferred Income Taxes | $5.0M | -$98.0M | $129.0M | -$3.0M | -$2.0M | -$1.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | $13.0M | $4.0M | $11.0M | -$1.0M | -$4.0M |
| Payments To Acquire Equity And Other Investments | $8.0M | $71.0M | $4.0M | $4.0M | $106.0M | $1.0M |
| Proceeds From Principal Repayments On Loans And Leases Held For Investment | $849.0M | $767.0M | $637.0M | $628.0M | $594.0M | $545.0M |
| Payments To Acquire Loans Held For Investment | $996.0M | $944.0M | $805.0M | $844.0M | $710.0M | $575.0M |
| Increase Decrease In Finance Receivables | ||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | ||||||
| Increase Decrease In Accounts And Other Receivables |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.94 | $1.55 | $0.10 | -$2.73 | -$0.30 | -$0.57 | -$0.13 |
| Weighted Average Number Of Shares Outstanding Basic | 1.30B | 1.29B | 1.28B | 1.27B | |||
| Weighted Average Number Of Diluted Shares Outstanding | 1.30B | 1.30B | 1.30B | 1.27B | |||
| Earnings Per Share Basic | $0.95 | $1.57 | $0.10 | $-2.73 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Diluted EPS * | $0.20 | $0.69 | -$0.53 | $0.64 | $0.13 | -$0.21 |
| Weighted Average Number Of Shares Outstanding Basic | 1.30B | 1.30B | 1.30B | 1.29B | 1.29B | 1.29B |
| Weighted Average Number Of Diluted Shares Outstanding | 1.31B | 1.31B | 1.30B | 1.30B | 1.30B | 1.29B |
| Earnings Per Share Basic | $0.20 | $0.70 | $-0.53 | $0.64 | $0.13 | $-0.21 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $232.0M | $61.0M | $60.0M | $17.0M | $1.6M | $140.0K | $295.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $449.0M | $430.0M | $615.0M | $549.0M | $8.2M | $3.9M | $1.5M |
| Stock Option Plan Expense | $449.0M | $430.0M | $615.0M | $549.0M | $7.8M | $3.8M | $1.4M |
| Foreign Currency Transaction Gain Loss Before Tax | $26.0M | -$8.0M | $1.0M | -$2.0M | -$1.2M | -$653.0K | -$537.0K |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -$8.0M | -$4.0M | $0.00 | $0.00 | $353.0K | $651.0K | $320.0K |
| Foreign Currency Transaction Gain Loss Unrealized | $57.0M | -$19.0M | $6.0M | -$12.0M | |||
| Provision For Doubtful Accounts | $230.0M | $148.0M | $80.0M | $74.0M | |||
| Additional Paid In Capital | $236.0M | $305.0M | $251.0M | $11.7M | $5.7M | ||
| Transaction And Loan Losses | $417.0M | $227.0M | $152.0M | $135.0M | |||
| Stock Issued During Period Shares Stock Options Exercised | 4.7M | 2.6M | 3.9M | 4.7M | 305.6K | ||
| Income Loss Attributable To Parent | $2.23B | $185.0M | -$3.62B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $24.0M | $44.0M | $59.0M | $6.0M | $3.0M | $3.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $107.0M | $113.0M | $114.0M | $110.0M | $106.0M | $105.0M |
| Stock Option Plan Expense | $107.0M | $113.0M | $114.0M | $110.0M | $106.0M | $105.0M |
| Foreign Currency Transaction Gain Loss Before Tax | -$4.0M | $24.0M | $6.0M | $16.0M | $2.0M | -$4.0M |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -$2.0M | -$1.0M | -$2.0M | -$2.0M | $0.00 | $0.00 |
| Foreign Currency Transaction Gain Loss Unrealized | -$4.0M | $46.0M | $12.0M | $19.0M | $2.0M | -$6.0M |
| Provision For Doubtful Accounts | $102.0M | $44.0M | $43.0M | $42.0M | $26.0M | $28.0M |
| Additional Paid In Capital | $272.0M | $281.0M | $279.0M | |||
| Transaction And Loan Losses | $148.0M | $80.0M | $75.0M | $58.0M | $42.0M | $51.0M |
| Stock Issued During Period Shares Stock Options Exercised | 1.2M | |||||
| Income Loss Attributable To Parent | $308.0M | $1.08B | -$770.0M | $860.0M | $203.0M | -$256.0M |
Most recent annual filing with the SEC: February 11, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.